18F-FDG PET/CT in a patient with lymph node metastasis from ovarian adenocarcinoma
| Autor: | E. Gontier, Jean-Louis Alberini, Jean-Marc Guinebretiere, Myriam Wartski |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
medicine.medical_specialty
endocrine system diseases Adenocarcinoma Metastasis Fluorodeoxyglucose F18 medicine Carcinoma Humans Radiology Nuclear Medicine and imaging Radionuclide Imaging Lymph node Aged Ovarian Neoplasms PET-CT business.industry Cancer Calcinosis General Medicine medicine.disease Primary tumor medicine.anatomical_structure Cervical lymph nodes Lymphatic Metastasis Female Radiology Radiopharmaceuticals Ovarian cancer business Tomography X-Ray Computed |
| Zdroj: | AJR. American journal of roentgenology. 187(3) |
| ISSN: | 1546-3141 |
| Popis: | WEB This a Web exclusive article. varian carcinoma is the third most common cancer of the female genital tract. It is the first cause of death from gynecologic malignancy, essentially because most patients present with advanced disease [1]. Serous adenocarcinoma is the most common histologic subtype of epithelial ovarian cancers (≈ 40%) [2]. Serous adenocarcinoma can contain microcalcifications, mainly in the primary tumor or in peritoneal metastases. More rarely, these calcifications occur in lymph node metastases and can be detected on radiologic imaging. Lymph node metastases must not be confused with old granulomatous disease or calcifications due to previous treatment. The diagnosis of calcified metastasis of ovarian papillary serous adenocarcinoma can be difficult in the supradiaphragmatic area, where such metastases are unusual. This case illustrates the usefulness of PET/CT using 18F-FDG for the detection of residual viable tumoral tissue in calcified cervical lymph nodes in a woman treated 16 years earlier for a papillary serous ovarian adenocarcinoma and presenting no clinical evidence of infradiaphragmatic tumor recurrence. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|